Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01ZZ1603[A-D] and Z1804[A-H] (DIFUTURE))
Deutsche Forschungsgemeinschaft (EXC 1010 SyNergy)
Received: 19 December 2019
Accepted: 4 June 2020
First Online: 20 June 2020
Ethics approval and consent to participate
: The study was approved by the local ethics committee from the Ludwig-Maximilians University. All participants gave written informed consent (project 159-03, 163-16 and 600-15).
: Not applicable.
: E. Mulazzani, D. Wagner, M. Schlüter, I. Meinl, and L.-A. Gerdes report no disclosures. J. Havla reports personal fees and non-financial support from Merck, Novartis, Roche, Santhera, Biogen, and Sanofi Genzyme and non-financial support of the Guthy-Jackson Charitable Foundation, all outside the submitted work.T. Kümpfel has received speaker honoraria including advisory boards from Bayer Healthcare, Teva Pharma, Merck, Novartis Pharma, Sanofi-Aventis/Genzyme, Roche Pharma, and Biogen as well as grant support from Novartis and Chugai Pharma in the past.